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Abstract
Intracranial atherosclerotic stroke differs from extracranial atherosclerotic 
stroke in many aspects, including risk factors and stroke patterns. It occurs in 
association with in situ thrombotic occlusion, artery-to-artery embolism, branch 
occlusion, and hemodynamic insufficiency. Intracranial atherosclerotic stenosis 
(ICAS) could have only been diagnosed by transcranial Doppler (TCD) and tran-
scranial color-coded sonography (TCCS), which are burdened by a risk of bias, or 
catheter angiography (DSA), which, on the contrary, is very precise, but rarely it is 
done in clinical practice due to its invasiveness. Computed tomography angiography 
(CT-A) and magnetic resonance imaging angiography (MR-A) have increased the 
identification of ICAS in a wider stroke population.
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1.  Epidemiology, natural history, and risk factors of intracranial 
atherosclerotic disease
1.1 The incidence of intracranial atherosclerotic disease (ICAD)
Intracranial atherosclerosis is one of the most important causes of stroke 
worldwide [1]. All major intracranial arteries are affected by atherosclerotic disease, 
and between 6 and 50% of all world ischemic strokes are the result of ICAD [2]. 
Intracranial arterial atherosclerotic stenosis (ICAS) represents the most advanced 
stage of ICAD, and thus nonstenotic ICAD is much more common than stenotic 
ICAD [3].
Regarding the incidence of ICAD, it varies especially by ethnicity. Population 
groups which are at high risk for ICAS include: Asians (30–50% of all new ischemic 
strokes) [4], Hispanics, and population of African descent; conversely, the risk is 
lower in Caucasians (8–10% of all new ischemic strokes) [5]. The reason for racial 
differences is still unclear. The main hypotheses include: low lipid levels and high 
blood pressure (susceptibility to intracranial and intracerebral vascular disease); 
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high lipids and high blood pressure (susceptibility to extracranial occlusive 
vascular lesions); and diabetes mellitus and metabolic syndrome (for ICAS) [2, 6, 
7]. Other studies include inherited susceptibility of intracranial vessels to athero-
sclerosis [8], acquired differences in the prevalence of risk factors [5], differential 
responses to the same risk factors [9], and different genetic susceptibility [7]. It 
is also possible that misclassifying patients with adult-onset Moya-Moya disease 
(MMD) as having ICAD may partly explain the high prevalence of ICAD in Asians 
[10]. A genome-wide linkage analysis and an exome analysis identified the stron-
gest susceptibility gene for MMD in East Asian people: ring finger 213 (RNF213) 
[10]. An important role in the emergence of these ethnic differences can be repre-
sented by the lifestyle: the pattern of ischemic stroke is changing in Asian patients; 
due to the westernized lifestyle, the number of extracranial cervical disease is 
rising [11].
1.2 Prognosis of asymptomatic intracranial atherosclerotic disease (ICAD)
Regarding the prevalence of asymptomatic ICAD in general population, 
information is still limited, in the absence of large clinical trials [12]. The 
atherosclerotic process develops silently over years, until its lesions suddenly 
become symptomatic. Accordingly, early diagnosis of ICAD may improve 
the therapeutic strategy, while the disease is still asymptomatic. However, 
the natural history of asymptomatic ICAD is not fully known, especially in 
Caucasians [3].
The natural history of asymptomatic versus symptomatic ICAD differs from 
that of extracranial carotid disease (ECAD). Patients with symptomatic ICAD 
have a low risk of stroke in the stenotic arterial territory, compared to patients 
with asymptomatic ECAD, while patients with symptomatic ICAD have a higher 
risk, especially those with clinically significant hemodynamic stenosis, early 
after stroke [13]. Therefore, recent studies suggest that the annual risk of stroke 
in asymptomatic patients with at least 50% stenosis of a major intracranial artery 
is less than 10% [14]. Furthermore, patients with severe intracranial stenosis 
(70–99%) have a higher risk of stroke than do patients with moderate intracranial 
stenosis (50–69%) [14].
Arenillas designed a population-based study [3], which comes to clarify the 
natural history and the prevalence of asymptomatic ICAD in Caucasians. Study 
subjects (1503) were randomly selected from a population of 600 000 inhabit-
ants, from March 2007 until June 2010. The primary enrollment criteria were: age 
over 50 years, no past history of cerebrovascular or ischemic heart disease, and 
moderate-to-high vascular risk. Presence and severity of ICAS were determined 
through the medium of transcranial color-coded duplex (TCCS) and subsequent 
MR angiography (MRA) confirmation. Preliminary results showed a prevalence of 
asymptomatic ICAD of 9% in the first 157 studied subjects [3].
Several transcranial Doppler (TCD) studies in an asymptomatic Asian popula-
tion have also been conducted. They have come to the conclusion that the preva-
lence of asymptomatic ICAS ranged from 5.9 to 24.5% [15].
1.3 Risk factors for intracranial atherosclerotic disease (ICAD)
Oh Young Bang reported various conditions and risk factors for ICAD, from risk 
factors associated with asymptomatic ICAD to risk factors for stroke recurrence 
[16]. ICAD risk could not be fully related to conventional risk factors for stroke; 
therefore, specialists are still investigating specific risk factors for ICAD [3].
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2.  The mechanisms of ischemia in intracranial atherosclerotic disease 
(ICAD)
According to Arenillas [3], our traditional understanding of ICAD is based on 
the detection of hemodynamically relevant intracranial arterial stenosis (ICAS).
The main limitations of this classical approach are as follows:
1. It may be restricted to the most advanced stage of ICAD alone [3].
2. It is unable to differentiate atherosclerosis from stenosis caused by other enti-
ties. The etiological differential diagnosis of the arterial stenosis includes ath-
erosclerotic disease, embolus with partial recanalization, arterial dissection, 
vasculitis, and vasospasm. Thus, it is important to note that while anatomic 
diagnosis of arterial narrowing can be made with appropriate accuracy using 
conventional imaging techniques, identifying the cause of stenosis involves 
iterative or multimodal imaging [3].
3. It may not be able to provide information about the histopathologic composi-
tion and activity of the intracranial atherosclerotic plaque. The importance of 
this last point is based on the fact that symptomatic intracranial atherosclerotic 
plaques are characterized not only by a higher degree of luminal stenosis but 
also by a richer content in lipid, intraplaque hemorrhage, and inflammatory 
cell infiltration, all of which are well-known determinants of plaque instability 
in the extracranial vasculature [3, 17].
Stroke associated with ICAD occurs in association with four mechanisms:
a. In situ thrombotic occlusion (with impaired anterograde flow). Plaque rupture 
reveals its thrombogenic core to clotting factors resulting a thrombus that can 
locally occlude the artery or even embolize distally. The term of “vulnerable 
plaques” refers to those ones with a large lipid core, the presence of intraplaque 
hemorrhage, or a thin or ruptured fibrous cap; this kind of plaques are liable to 
suffer anytime a rupture. Patients with unstable intracranial plaques may show 
large territorial lesions via sudden thrombotic occlusion [16].
b. Artery-to-artery embolism. This mechanism commonly causes multiple 
cortico-subcortical infarcts [16].
c. Hemodynamic insufficiency/failure (with impaired collateral flow and cer-
ebrovascular reserve). Severe narrowing or occlusion of the lumen may lead to 
hypoperfusion of the distal brain territory, especially in patients with inad-
equate collateral flow. The hypoperfusion through a stenotic intracranial artery 
causes watershed or border-zone strokes [16].
d. Branch occlusion disease (BOD) is one of the main stroke mechanisms of 
ICAD. This mechanism, specific to ICAD, consists in growing of the plaque 
over the ostia of penetrating arteries. It is defined by a milder degree of stenosis 
and comma-shaped infarcts extending to the basal surface of the parent artery. 
BOD has been related to cryptogenic strokes [16, 18].
Thus, even mild stenosis of intracranial atherosclerotic arteries (<50%) may 
be clinically relevant, and high-resolution magnetic resonance imaging (HR-MRI) 
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studies are needed to identify and determine the degree and location of stenosis in 
this patient group [19]. Oh Young Bang and others asserted that these mechanisms 
can coexist and interact in the same patient [16, 18, 20, 21].
2.1 Clinical recurrence rate
As we mentioned before, the annual recurrence rates for any ischemic stroke 
reported in the WASID trial were as high as 15 and 14% in the aspirin and warfarin 
arms, respectively [16].
It has been shown that symptomatic ICAD is particularly burdened with a high 
clinical recurrence rate [3]. Moreover, Famakin and coworkers reported that most 
subsequent strokes in patients with symptomatic ICAS occurred in the same arte-
rial territory were nonlacunar, and nearly half of them were disabling [19]. Their 
results were similar to the findings in NASCET, which showed that 95% of strokes 
were ipsilateral in patients with 70–99% carotid stenosis, and 71% of strokes were 
ipsilateral in patients with 50–69% carotid stenosis [22].
It is also important to mention that Famakin and coworkers observed that 
patients with ICAS have a propensity for atherosclerotic stenosis at different sites 
within the intracranial circulation [19]. Supporting this idea, they reported that 
among the 27% of the strokes occurring outside the territory of the symptomatic 
intracranial artery, almost half (48%) could have been caused by previously 
asymptomatic or newly developed ICAS in a different vascular territory. However, 
in the same study, it was suggested that it is also possible that some of these strokes 
may have been caused by an embolus which partially recanalized leaving a residual 
stenosis [19]. Supporting this theory is data from another WASID analysis, which 
showed that asymptomatic ICAS that was present at study entry (coexistent with 
the symptomatic stenosis) was associated with a low rate of stroke (3.5% after 1 
year of follow-up) [23].
Identifying whether ICAS is actually the cause of the present stroke (determin-
ing whether the stenosis is symptomatic or asymptomatic), it is however still a 
challenge, knowing that, according to Famakin, in up to 20% of the patients with 
stroke and IACS, there is another cause for its occurrence (extracranial large artery 
stenosis, cardiac embolism, and small artery occlusion can co-exist with ICAS) 
[19]. Nowadays, different noninvasive imaging techniques can provide physiologi-
cal data on the mechanisms associated with ICAD-linked stroke and their forms of 
coexistence, including markers of anterograde and collateral flow, dynamic cerebro-
vascular reserve, static tissue perfusion, characteristics and morphological details 
of plaques with embolic potential, etc. [16, 18, 24].
All these data may improve stroke risk stratification, adding to clinical and 
anatomic (i.e., percent stenosis) predictors of stroke risk, developing mechanism-
specific prevention and treatment strategies, and also serve in patients’ selection for 
endovascular therapies [16, 18, 24].
3.  Catheter-based digital substraction angiography (DSA)—diagnostic 
test for intracranial arterial stenosis (ICAS)
Catheter-based digital subtraction angiography (DSA) is the gold standard in 
the diagnosis of ICAS. ICAS is considered as symptomatic, if there are obvious 
radiological signs of acute ischemia in the supplying vascular area and if no other 
obvious cause (e.g., acute occlusion) is present.
Regarding the advantages of DSA, it allows [12]: the visualization of vessel 
contour—at a high resolution (microns); the localization of stenosis; and the 
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estimation of degree and length of stenosis (DSA measures stenosis precisely); 3D 
reconstruction provides even greater detail, highlighting of collateral circulation 
(measure anterograde and collateral flow). Prabhakaran and coworkers suggested 
that DSA can identify the mechanisms of stroke in symptomatic ICAS by using sur-
rogate imaging markers of stroke risk [12]: for the mechanism of decreased antegrade 
flow—the surrogate imaging marker of TICI (thrombolysis in cerebral infarction) 
flow grade; for the mechanism of progression of stenosis—the surrogate imaging 
marker of TICI (thrombolysis in cerebral infarction) flow grade; and for the mecha-
nism of poor collateral flow—the surrogate imaging marker of collateral flow grade. 
However, being an invasive method that can generate periprocedural complications 
(periprocedural neurologic injury, access site injury, radiation risks, contrast risks, 
low availability, and great costs), DSA cannot be used in everyday routine clinical 
practice, in all patients [25].
3.1  DSA allows an excellent visualization of intracranial arterial contour, at a 
high resolution (microns)
Monitoring the natural history of stenosis due to ICAD may be a useful method 
in finding new possible treatments. Long-term angiographic progress of ICAS has 
not received much attention before WASID trial; Bauer et al. [26] reported the 
progression of atherosclerotic stenoses by location, including extracranial and 
intracranial sites. Overall, 35.3% of intracranial sites progressed. Craig et al. [27] 
noted that intracranial ICA stenoses progressed in 5 of 5 patients on follow-up 
angiography. Akins and coworkers retrospectively reviewed records over a 7-year 
period to identify patients with ICAS and serial angiograms. The most common 
location for an ICAS of 50% or greater was the intracranial portion of the ICA (49% 
of lesions), followed by the MCA (20%), PCA (11%), distal VA and BA (11%), and 
ACA (9%) [28].
Angiography is an excellent method for monitoring intracranial atherosclero-
sis, but this method defines the vessel lumen only; the disease process leading to 
luminal narrowing being inferred [28]. If the patient has widespread atheroscle-
rosis, the stenosis is usually ascribed to this. The arterial narrowing is generally 
caused by local atherosclerosis, but associated thrombus may also contribute. 
Emboli also cause luminal narrowing. In this situation, the follow-up study may 
show the complete resolution of the stenosis due to spontaneous clot lysis. This 
pattern was encountered in 3 of the 45 sites studied by Akins. He noted that 
there are also other pathological conditions that can cause vessel narrowing, such 
as vasculitis, vasospasm, or malignancies. He concluded that ICAS is dynamic 
lesions [28].
3.2  DSA allows an excellent localization and evaluation of the degree and length 
of intracranial arterial stenosis (ICAS)
Angiographic measurement methods are routinely used nowadays in clinical 
practice to identify patients who may benefit from carotid endarterectomy [29]. 
Samuels affirmed that the established methods for measuring extracranial ICA 
stenosis are unsuitable for measuring the stenosis of a major intracranial artery 
because the intracranial arteries are often tortuous, have several branches, and are 
narrowing gradually in their distal portions [29].
If the prognosis of ICAS and the choice of therapy for these patients was clearly 
shown by WASID trial [2] to be based on the severity of ICAS, a repeatable method 
for measuring percent stenosis of the major intracranial arteries was required: 
standard WASID criteria for grading of ICAS [29].
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All patients enrolled in the WASID trial have been subjected to DSA, to confirm 
a symptomatic ICAS (50–99%) of the ICA, MCA, VA, or BA. All major intracranial 
vessels were screened for stenosis stratified into three categories of lumen reduction 
(30–50, 50–70, and >70%). The percentage of stenosis of an intracranial artery was 
defined by Samuels [29].
  WASID method [1 − (Dstenosis/Dnormal)] × 100 = % Stenosis . (1)
Rules applied for measuring a stenosis of the carotid siphon and basilar artery.
Dstenosis is the residual diameter of the artery at the site of the most severe steno-
sis, and Dnormal is the diameter of the proximal normal artery.
• If the proximal segment is diseased, contingency sites are chosen to measure D 
normal: distal artery (second choice) or feeding artery (third choice).
• If tandem intracranial lesions are present (e.g., distal vertebral and mid-
basilar), percent stenosis of both sites is measured and the more severe stenosis 
is selected.
When a “gap sign” is present (i.e., the lumen of the vessel cannot be visualized 
at the site of severe stenosis), D stenosis cannot be measured with calipers. In these 
cases, percent stenosis is defined as 99% luminal stenosis [29].
3.3 DSA is an excellent assessor of collateral intracranial arterial circulation
Cerebral collateral circulation is a supplementary vascular channels network 
that plays an important role in stabilizing the cerebral blood flow when the main 
arterial supplying systems fail (Liebeskind and coworkers) [30, 31]. Arterial insuf-
ficiency due to thromboembolism, hemodynamic compromise, or a combination of 
these factors may lead to the recruitment of collaterals [30, 31].
Impaired cerebral hemodynamics is a well-established predictor in large artery 
stroke [32]. Cerebral perfusion pressure distal to a high-grade stenosis or occlusion 
depends on collateral sources of blood flow. The anterior and posterior communi-
cating arteries (ACoA, PCoA) provide most collateral flow in ICA and BA stenosis 
(primary collaterals), while distal pial and leptomeningeal anastomoses (secondary 
collaterals) are important in MCA stenosis [32]. DSA is the most valuable inves-
tigation that provides the assessment of collateral cerebral flow; Liebeskind and 
coworkers reporting that collateral flow on DSA was found to be absent in 69% of 
patients with symptomatic ICAS and it was also considered an independent predic-
tor of recurrent ipsilateral stroke [30, 31].
Stroke risk, due to ICAD, increases with the arterial stenosis degree. Liebeskind 
and coworkers conducted a retrospective analysis of the baseline DSA acquired in 
the WASID trial, and they provided the first comprehensive evaluation of collater-
als in modifying stroke risk in patients diagnosed with ICAD and its impact on 
subsequent stroke characteristics. They observed that the collateral circulation was 
adequately available for analysis in 287/569 patients from WASID (50%) subjects 
with proximal arterial stenoses ranging from 50 to 99% [30, 31].
According to Liebeskind, collateral brain circulation is one of the most signifi-
cant factors that mediates the potentially devastating effects of cerebral ischemia. 
He asserted that patho-physiological recruitment of these collateral vessels (poten-
tial anastomotic connections) depends on the temporal course of numerous com-
pensatory (hemodynamic, metabolic, and neural) mechanisms and on the caliber 
and patency of primary pathways that may rapidly compensate for decreased 
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blood flow and the adequacy of secondary collateral routes [30, 31]. He asserted 
that collaterals maintain perfusion downstream from arterial occlusions in acute 
stroke, determining the hemodynamic characteristics of the ischemic penumbra, 
the evolution of infarct, and susceptibility for hemorrhagic transformation [30]. 
He suggested that focal neurologic symptoms manifest only when collaterals fail. 
Regarding the therapeutic point of view, robust collaterals are an effective predictor 
of arterial recanalization and good clinical outcomes in acute stroke [31]. It is also 
well known that arterial occlusion secondary to progressive atherosclerotic stenosis 
of an intracranial segment allows the development of robust collaterals over time, 
unlike the cardioembolic or abrupt thrombotic occlusion. Collaterals and functional 
demonstration of flow impairment may be more informative than isolated anatomic 
measures of maximal stenosis or length [30].
Liebeskind concluded that collateral circulation is a powerful determinant 
of stroke risk in ICAD, demonstrating a protective role with severe stenoses and 
perhaps distinguishing milder stenoses that are relatively unstable [30, 31].
4.  Transcranian Doppler (TCD) and transcranian color—coded 
sonography (TCCS)—diagnostic tests for intracranial arterial 
stenosis (ICAS)
Intracranial circulation can be examined by transcranial Doppler ultrasonog-
raphy (TCD) or transcranial color-coded duplex sonography (TCCS) through 
different bone windows (transtemporal, transforaminal, and transorbital). The 
signal can be enhanced by using ultrasound contrast agents [33–38]. TCD com-
bines in real-time intracranial blood flow patterns and velocities modifications 
with arterial diameter in the stenotic vessels. The most important data are: depth, 
blood flow direction, different velocities (peak systolic-PSV, end diastolic-EDV, 
and mean blood flow velocity-MFV), pulsatility index-PI, and resistance index-
RI. The physiological data assessed from TCD are complementary to the anatomi-
cal data analyzed from other neuroimaging techniques (DSA, CTA, and MRA) 
[33–38].
TCD has some advantages: inexpensive, noninvasive, portable test than can be 
performed bedside, serial examination, emboli detection, and vasomotor reactivity 
testing. TCD has high specificity, sensitivity, and negative predictive value (NPV) 
[33–38]. In the same time, TCD has some disadvantages: low reliability, technical 
limits (inadequate or absent windows, the tortuous course of the basilar artery, 
etc.), and operator-dependent results. TCD presents a modest positive predic-
tive value (PPV) (36–75%). Therefore, it is useful to exclude significant ICAS 
with high certainty but requires confirmation by other imaging methods when 
stenosis is suggested [33–41]. The circle of Willis is complete in only 20% of cases; 
in other cases, one or several vascular segments may be hypoplastic or aplastic. 
Visualization of the intracranial vessels and assessment of cerebral hemodynamics 
are only possible with TCCS, but this technique still requires further certification 
in larger studies [33–41].
Prabhakaran and coworkers suggested that TCD can specify the mechanisms 
of stroke in symptomatic ICAS by using surrogate imaging markers of stroke risk: 
for the mechanism of decreased antegrade flow—the surrogate imaging marker of 
flow velocity; for the progression of stenosis—the flow velocity; for the poor col-
lateral flow—the circle of Willis collaterals; for the artery-to-artery embolism—the 
microembolic signal; and for the impaired vasomotor reactivity—the cerebrovas-
cular reactivity [33–41]. Serial monitoring of flow velocities by TCD can detect the 
evolution of ICAS and therapeutic effects [22, 41].
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Transcranial ultrasound is used for multiple aims: TCD/TCCS can detect, 
localize, and grade the severity of ICAS; can detect and localize the intracranial 
arterial occlusion; can realize the real-time monitoring of recanalization in 
patients treated with systemic thrombolysis and of rescue reperfusion techniques 
(identification of reocclusion, hyper-perfusion syndrome, etc.); can detect 
clinically silent emboli: microembolic signals (MES), which recognizes patients 
at higher risk of embolic stroke; can recognize patients with extracranial internal 
carotid artery (ICA) stenosis at a higher stroke risk; can assess both collateral 
pathways and the vasomotor reactivity (VMR), which detects the risk stratifica-
tion of hemodynamic stroke [22, 33, 37, 41]; and can identify intracranial arterial 
blood flow steals.
4.1 TCD/TCCS can detect, localize, and grade the severity of ICAS
In clinical practice, interpretation of TCD data should be individualized, with 
various parameters (velocities values, spectrum, waveform patterns, flow pulsatil-
ity, collateral flows, status of extracranial arteries, systemic conditions: anemia, 
etc.) (Tables 1 and 2) [35]. TCD presents higher precision for identification of 
ICAS in the MCA and BA than in other intracranial arteries, due to the tortuosity in 
the latter [33].
ICAS criteria are direct and indirect.
Artery Stenosis >50% (MFV, 
SPR)
Stenosis >70% (MFV, 
SPR)
Diffuse disease or near occlusion 
(MFV, SPR)
MCA >100 cm/s, >2 >120 cm/s, >3 <30 cm/s, <1
ACA >80 cm/s, >2 n.a., >3 <30 cm/s, <1
PCA >80 cm/s, >2 n.a., >3 <30 cm/s, <1
BA >90 cm/s, >2 >110 cm/s, >3 <20 cm/s, <1
VA >90 cm/s, >2 >110 cm/s, >3 <20 cm/s, <1
MCA, middle cerebral artery; ACA, anterior cerebral artery; PCA, posterior cerebral artery; BA, basilar artery; VA, 
vertebral artery; MFV, mean flow velocity; n.a., not available; and SPR, stenotic/prestenotic MFV ratio.
Table 1. 
TCD criteria for intracranial stenosis (ICAS) [33].
Artery Mild stenosis Moderate stenosis Severe stenosis
Stenosis <50% (PSV) Stenosis >50% (PSV) Stenosis >80%
MCA >155 cm/s >220 cm/s +Indirect signs
ACA >120 cm/s >155 cm/s +Indirect signs
PCA >100 cm/s >145 cm/s +Indirect signs
BA >100 cm/s >140 cm/s +Indirect signs
VA >90 cm/s >120 cm/s +Indirect signs
MCA, middle cerebral artery; ACA, anterior cerebral artery; PCA, posterior cerebral artery; BA, basilar artery; VA, 
vertebral artery; and PSV, peak systolic velocity.
Table 2. 
TCCS criteria for intracranial stenosis (ICAS) [42].
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A. Direct criteria (modifications observed at the stenosis level) include:
a. A color aliasing phenomenon (only in TCCS exam), which may indicate 
augmented flow velocities, caused by a stenosis or other etiologies (tortuos-
ity, etc.) [35].
b. A progressive focal increase of blood flow velocities in ≥50% stenosis or 
paradoxical velocity decrease with very severe stenosis, near-occlusion or 
diffuse intracranial disease (Figures 1, 2).
Figure 2. 
TCDS transtemporal approach, axial, midbrain plane, color mode (left C1 stenosis).
Figure 1. 
TCDS, transtemporal approach, axial midbrain plane, color mode (left M1 higher grade stenosis).
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Baracchini noted that, as a rule for a vessel with straight walls, a 50% diameter 
reduction double the velocity, and a 70% stenosis may triple the velocity at the end 
of the stenosis compared with a prestenotic segment or with the contralateral no 
affected side. The velocity values detected by TCCS are higher than those by TCD 
(due to angle correction) [35].
c. A significant (>30%) side-to-side difference of velocity (for symmetrical 
vessel segments after angle correction) [35].
B. Indirect criteria (changes observed in other arteries):
a. Only observed in very severe stenosis (>80%).
b. Are the same as for occlusion—proximal or distal flow alterations: a diastolic 
velocity drop; high RI in the feeding vessel or in the proximal segment of 
the stenotic vessel; a delayed systolic flow augmentation and velocity drop 
downstream; and flow diversion and signs of collateralization [35, 41–43].
TCD criteria for ICAS in anterior as well as posterior circulation have been 
validated against DSA, MRA, and CTA, and serve as reliable tools for their diagno-
sis (Table 1) [33].
The velocity criteria for ≥50% ICAS were detected by Feldmann and cowork-
ers in (SONIA) trial [39], which standardized the data of TCD, MRA, and 
DSA. The cut points were the measures of continuous variables such as the 
percentage of stenosis on MRA or velocity on TCD for each intracranial arterial 
vessel:
a. MRA ≥50% stenosis, without occlusion, or the presence of a flow gap defined a 
positive test. Stenosis ≥50% on TCD was identified using an MFV >100 cm/s in 
MCA, >90 cm/s in the intracranial ICA, or >80 cm/s in the BA or VAs [39].
b. For 80% stenosis on MRA, the SONIA TCD-MFV (cm/s) cut points for 
70–99% DSA stenosis of different arteries were: MCA 240, ICA 130, BA 130, 
and VA 130 [39].
SONIA trial established that both TCD and MRA could reliably exclude the 
presence of ICAS, rather than identifying them; abnormal findings on TCD or MRA 
requiring a confirmatory test such as DSA to diagnose ICAS [39].
The correlation between TCD and DSA for the identification of ≥50% ICAS at 
laboratories with (SONIA) TCD scanning protocol was established by Limin Zhao and 
coworkers [40]. Stenosis ≥50% on TCD was detected using an MFV >100 cm/s in the 
MCA, >90 cm/s in the intracranial ICA, or >80 cm/s in the VAs/BA. For ≥70% ICAS, 
they used expanded criteria (MFV-MCA >120 cm/s, MFV-VAs/BA >110 cm/s, stenotic/
prestenotic velocity/ratio-SPR ≥3, and low velocity). These criteria demonstrated 
excellent-to-good sensitivity of TCD and indicated good agreement with DSA [40].
Baumgartner and coworkers conducted a TCCS study that evaluated PSV cutoff 
values for the assessment of >50 and <50% stenosis of the intracranial arteries 
(Table 2) [42].
4.2 TCD/TCCS can detect and localize the intracranial arterial occlusion
Intracranial occlusion can be directly or indirectly detected by ultrasound 
examination.
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a. Direct criteria for intracranial arterial proximal occlusion are diagnosed using 
the thrombolysis in brain ischemia (TIBI) flow-grading system. They include: 
no flow signal (TIBI 0) and minimal flow signal (TIBI 1), while blunted flow 
signal (TIBI 2) and dampened flow signal (TIBI 3) are criteria for distal occlu-
sion (Figure 3). A missing flow signal could be occlusion or hypoplasia/aplasia 
(it is essential to use ultrasound contrast agents and to verify for indirect 
criteria of intracranial arterial occlusion) [35, 36, 43, 44].
b. Indirect criteria for intracranial arterial occlusion comprise proximal or distal 
flow alterations: a diastolic velocity drop; high RI in the feeding vessel or in the 
proximal segment of the stenotic vessel; a delayed systolic flow augmentation 
and velocity drop downstream; and flow diversion and signs of collateraliza-
tion (Figure 4) [33–38].
4.3  TCD/TCCS can realize the real-time monitoring of recanalization in acute 
ischemic stroke patients treated with systemic thrombolysis and of rescue 
reperfusion techniques (identification of reocclusion, hyperperfusion 
syndrome, etc.)
TCD/TCCS can detect the residual flow at thrombus-blood interface.
The TIBI flow grading system, TIBI: 0–5, was elaborated to identify residual 
flow and to monitor thrombus dissolution in real time [37, 43–45].
Absent flow (TIBI 0): no flow signals; or lack of regular pulsatile flow signals 
(using lowest pulse repetition frequency-PRF and increased color-gain settings).
Minimal (TIBI I): systolic spikes of variable velocity and duration; and absent 
diastolic flow during all cardiac cycles.
Blunted (TIBI II): flattened or delayed systolic flow acceleration compared 
with control side; positive end-diastolic velocity (EDV); and pulsatility index 
(PI) <1.2.
Dampened (TIBI III): normal systolic flow acceleration; positive EDV; and 
>30% decrease in mean flow volume (MFV) compared with control side.
Figure 3. 
Thrombolysis in brain ischemia (TIBI) flow-grading system.
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Stenotic (TIBI IV): MFV >80 cm/s and velocity difference >30% compared with 
control side; if the velocity difference is <30%, look for additional signs of stenosis; 
and affected and comparison sides have MFV <80cm/s.
Normal (TIBI V): <30% MFV difference compared with control side; and 
similar wave form shapes compared with control side [37, 43–45].
TIBI flow grades I–III correspond to acute proximal intracranial artery occlu-
sion, while a TIBI flow grade of IV is an indicative of proximal artery hemodynami-
cally significant (>50%) stenosis.
The assessment of the diagnostic value of transcranial power motion-mode 
Doppler (PMD-TCD) against computed tomography angiography (CTA) in 
patients with acute ischemic stroke was evaluated by Tsivgoulis and coworkers. 
They asserted that PMD-TCD detected a substantial proportion of ICAS or occlu-
sions, in concordance with CTA in patients with acute ischemic stroke. PMD-TCD 
identified data supplementary to the CTA: collateralization of flow with extracra-
nial ICA stenosis/occlusion; real-time embolization-MES; and arterial blood flow 
steal [45].
The evaluation of the diagnostic value of PMD-TCD against DSA in the detec-
tion of acute posterior circulation steno-occlusive disease was realized by Tsivgoulis 
and coworkers. They showed that the higher value of PMD-TCD compared with 
single-gate TCD may be associated with its ability to observe flow on the PMD dis-
play along tortuous and long arterial segments that may not be readily identified by 
sonographers during a single-gate TCD exam. In conclusion, PMD-TCD can exclude 
vertebro-basilar artery occlusion and can select patients for DSA and endovascular 
interventions if the sonographers are confirmed by DSA [46].
An acute arterial occlusion differs from chronic as it is often partial and 
incomplete and exhibits dynamic processes (partial obstruction to flow, thrombus 
propagation, reocclusion, and sometimes spontaneous recanalization). TCD can 
rapidly identify patients with these lesions and detect not only the flow-limiting 
lesion but also the ongoing embolization, the collateralization, and the failure of the 
vasomotor reserve [37].
Figure 4. 
TCDS, transtemporal approach, axial midbrain plane, color mode (right proximal ICA occlusion, with right 
M1-MCA poststenotic flow pattern).
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4.4  TCD can identify clinically silent emboli: microembolic signals (MES), 
which recognizes patients at higher risk of embolic stroke
MES detection in different interventional procedures (cerebral and coronary 
angiography, angioplasty, carotid endarterectomy, etc.) and in patients with extra 
and intracranial large artery atherosclerotic stenosis is useful in risk stratification, 
thus enabling to select those patients who could benefit from a more aggressive 
treatment [33, 41, 47]. MES detection requires continuous monitoring (at least 1 
hour) of the major intracranial arteries. Most MES can be detected several days 
after the embolic event. The origin of emboli is important; the detection of an 
embolic signal in the distal MCA might represent an atherosclerotic plaque in the 
ipsilateral MCA or ICA. On the other hand, the identification of MES in multiple 
bilateral arteries indicates a cardiac origin [33, 41, 47].
4.5  TCD can recognize patients with extracranial ICA stenosis at a higher stroke 
risk, can assess both collateral pathways, and the vasomotor reactivity 
(VMR), which detects patients at higher risk of hemodynamic stroke
Severe extracranial ICA stenosis may produce embolic or hemodynamic hemi-
spheric infarct [48]. While the risk of an embolic ischemic stroke increases with the 
severity of ICA’s stenosis, the hemodynamic risk correlates less well with the degree 
of stenosis because of the functional capacity of the collateral pathways [48]. A 
complete circle of Willis and the possibility to activate primary collaterals (anterior 
communicating artery-ACoA, posterior communicating artery-PCoA) or second-
ary collaterals (ophthalmic artery-OA, lepto-meningeal arteries) reduce the risk 
of hemodynamic infarct ipsilateral to the extracranial ICA disease [33, 36, 38]. In 
patients with collateral flow signals (reversed OA, anterior cross-filling, and PCoA 
flow) identified by TCD, proximal ICA occlusion is confirmed by subsequent neck 
CTA, MRA, or DSA [33, 36, 38].
Vasomotor reactivity (VMR) defines the autoregulatory vasodilation of cerebral 
vessels in response to a vasodilatory challenge, such as hypercapnia or acetazolamide 
(apnea test, breath-holding test, and Diamox test). VMR represents a measure of 
dynamic cerebrovascular reserve capacity. Its study recognizes patients at higher 
risk of hemodynamic stroke, in both intra and extracranial large vessel disease, thus 
allowing to select those patients who could benefit from a more aggressive treatment 
[38, 48]. According to Prabhakaran, the presence of MES, poor collateral flow, and 
impaired VMR predict the high risk of recurrence in intracranial atherosclerosis [41].
TCD can identify intracranial arterial blood flow steals (reversed Robin Hood 
syndrome).
Intracranial arterial blood flow steals can be detected in chronic disease (e.g., 
subclavian artery stenoses, arterio-venous malformations, and fistulas) but also in 
patients with acute ischemic stroke. Flow diversion is the hallmark of a steal and 
can appear at any level of the intracranial arteries (large proximal vessels and small 
distal vessels) [33–35].
5.  Magnetic resonance angiography (MRA) and high-resolution 
magnetic resonance imaging (HR-MRI) for the diagnosis of 
intracranial atherosclerotic disease (ICAD)
ICAD includes two major features: (a) atherosis caused by lipid deposits in the 
intima of the arteries and inflammation; and (b) sclerosis, as a result of endothelial 
dysfunction, leading to arterial stiffness [49].
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Strokes associated with ICAD occur in association with four major stroke 
mechanisms: in situ thrombotic occlusion; branch occlusion; artery-to-artery 
embolism; and hemodynamic insufficiency [50, 51]. Unstable intracranial plaques 
can suddenly lead to thrombotic occlusion. Using transcranial duplex monitoring, 
artery-to-artery embolism can be discovered, which commonly causes multiple 
cortico-subcortical infarcts. Branch occlusive disease (BOD) is one of the main 
stroke mechanisms of ICAD, which can be characterized by a milder degree of 
stenosis [19] and comma-shaped infarcts extending to the basal surface of the par-
ent artery [52].
The first two mechanisms are the consequences of plaque rupture, which reveals 
the thrombogenic core to clotting factors, resulting a thrombus that occludes the 
artery locally or embolizes distally [50].
The third mechanism, specific to ICAD, is the growth of plaque over the ostia 
of penetrating arteries resulting in occlusion, which was described by Caplan [53] 
as branch atheromatous disease. Lastly, high-grade narrowing or occlusion of the 
lumen may lead to the fourth mechanism: hypoperfusion of the distal brain terri-
tory, particularly in cases with inadequate collateral flow [31, 50].
MRA, CTA, DSA, TCD, and TCCS can detect ICAS of different histopathologi-
cal nature (including partially recanalized emboli) and can assess ICAS progression 
and in-stent restenosis. Unfortunately, these methods are unable to directly exam 
plaque instability, with the exception of microembolic signals (MES) detection by 
TCD as a surrogate marker [3].
Arenillas suggested that for the detection of intracranial plaque morphology, the 
imaging techniques used include high-resolution MRI (HR-MRI), high magnetic 
field (3T) preferable, and intravascular ultrasound. This new concept allows the 
detection and characterization of nonstenotic intracranial atheroma, establishing 
its role in stroke of undetermined origin, and may have the power to confirm the 
atherosclerotic nature of ICAS [3].
5.1 Magnetic resonance angiography (MRA)
Degnana noted that 3D time-of-flight (TOF)-MRA is a imaging technique 
that noninvasively explores the intracranial arteries. It takes the advantage of the 
contrast between nonsaturated spins in the blood entering the imaging plane and 
the stationary adjacent tissue, which remains saturated. 3D TOF-MRA allows the 
visualization of any variation in blood flow. It provides detailed information about 
the lumen status of the intracranial vessels (Figure 5) [54].
The following arterial segments are assessed: bilateral intracranial ICA, ACA-A1/
A2, MCA-M1/M2, PCA-P1/P2, BA, and VA. According to the severity of stenosis, 
there are four groups in which patients are classified: <50% or no stenosis, 50–69% 
stenosis, 70–99% stenosis, and occlusion groups. Focal flow void found on MRA 
with distal filling is considered as severe stenosis (70–99%) [55].
Other MR sequences, such as T2-/T1-weighted imaging, fluid-attenuated 
inversion recovery sequences, and diffusion-weighted imaging (DWI), are also 
performed on a conventional MRI on a 3.0 or 1.5T MR scanner [56].
Degnana asserted that MRA offers good equivalency with DSA for the detection 
of >50% stenosis with the reported sensitivity, specificity, and accuracy of 92, 91, 
and 91%, respectively [54].
Higher field strength scanners may carry additional benefits in improving signal 
intensity-to-noise ratio and background suppression; other sequences, such as novel 
sensitivity encoding (SENSE) TOF-MRA protocols, also have substantially abbrevi-
ated acquisition times [57].
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MRA has some advantages: noninvasive, no radiation, low cost, and widely 
available, but for the detection of ICAS requires confirmation by another imaging 
modality [51, 54]. The main disadvantage is that it overestimates stenosis. MRA can 
render ambiguous or erroneous results. The inability to distinguish between high-
grade stenosis and occlusion is another major disadvantage [58].
In addition, MRA has magnet contraindications: limited to no use in morbidly 
obese and claustrophobic patients and those with implanted metallic objects [51]. 
Although CTA performs better overall compared with MRA for the purpose of 
determining the degree of stenosis (CTA can better visualize high-grade stenoses 
than MRA since the latter tends to overestimate the degree of stenosis), MRA is bet-
ter than CTA at evaluating the petrous and cavernous ICA as bony artifacts affect 
CTA [51, 54].
Degnana noted that MRA can be superior in the evaluation of MCA stenosis 
compared with DSA but still only provides information about vessel patency alone. 
MRA can be an effective screening technique for patients with suspected MCA 
syndromes to detect stenosis within the intracranial vessels and to indicate the need 
for HR-MRI to accurately image the stenotic region [54, 59].
5.2 Contrast-enhanced (CE) MRA
It provides better anatomic visualization, particularly in the regions of changing 
blood flow directions; however, the visualization of smaller arteries remains limited 
[54, 60].
5.3 Quantitative MRA (QMRA)
Prabhakaran noted that QMRA, utilizing phase-contrast techniques, quantifies 
anterograde blood flow at distal site of stenosis; it exploits the phase shift in the 
signal of flowing blood, which is proportional to flow velocity, to quantify flow rate 
in medium and large vessels [51].
5.4 High-resolution MRI (HR-MRI)
The conventional imaging such as DSA, MRA, CTA, and TCD fall short in char-
acterizing the presence of no occlusive atherosclerotic disease, because it focuses on 
the vessel lumen estimate luminal stenosis by measuring blood flow velocity [2, 54].
Figure 5. 
Comprehensive imaging of a patient with recent stroke depicting left MCA stenosis. A−C, DSA (A) confirms 
stenosis, but contrast – enhanced MRA (B) and volume-reduced TOF MRA (C) overestimate the degree of 
stenosis in this particular case [54].
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HR-MRI can be used to assess intracranial arterial disease, both atherosclerotic 
and nonatherosclerotic [50].
According to Bodle, HR-MRI represents MR acquisitions using clinically avail-
able 1.5–3.0 Tesla magnetic field strength targeted to intracranial arterial pathology 
that are of sufficient quality to visualize the arterial wall, separate from the lumen 
of the proximal circle of Willis vessels. HR-MRI can be accomplished at 1.5 T by lim-
iting the field of view to focus on a single vessel or point of interest, but higher field 
strength at 3 T has many advantages over conventional MRI (1.5 T). Image quality 
in MRI depends on several factors (e.g., slice thickness, field of view, signal-to-noise 
ratio, matrix size, and magnetic field strength) [50, 61]. Image acquisition is faster 
and there are increased signal-to-noise and contrast-to-noise ratios, with better 
image quality for black-blood imaging. The increased signal and contrast that 3 T 
provides improves the detection of complex atherosclerotic plaque and can identify 
plaque components in larger arteries [50, 62].
HR-MRI allows the direct assessment of intracranial atherosclerotic plaques; it is 
capable of characterizing plaque location, severity, and morphology, and discrimi-
nating from other nonatherosclerotic etiologies [3, 50, 51].
Bodle also suggested that an intracranial plaque with HR-MRI features of 
intraplaque hemorrhage and a ruptured fibrous cap in a patient with downstream 
ischemia is likely associated with artery-to-artery embolism, whereas a stable 
plaque with a large amount of fibrous tissue and small lipid core resulting in 
high-grade stenosis may cause hypoperfusion [50]. Thus, HR-MRI may directly 
determine stroke mechanism and play a role in selecting secondary prevention 
therapies (e.g., patients with hypoperfusion may benefit from intracranial revas-
cularization procedures that patients with artery-to-artery embolism may not 
benefit) [50].
The simplest use of HR-MRI of the MCA is the calculation of the degree of MCA 
stenosis, which may be stated as:
  %Stenosis =  (1 − Lumen area / Reference lumen area) × 100, (2)
where the reference lumen area is the area of the nonoccluded lumen, preferably 
at a proximal segment [2].
Bodle mentioned that ICAS can be caused by diverse pathologies (e.g., athero-
sclerosis, inflammation, and vasospasm), with diverse treatment implications. 
HR-MRI may noninvasively differentiate between the etiologies of ICAS by identi-
fying plaque components or unique enhancement patterns [50].
Patients with symptomatic (versus asymptomatic) and non-BOD type (versus 
BOD) ICAD had characteristic changes in: (a) the wall area (larger plaques); (b) 
plaque signals (eco-centric enhancement and heterogeneous signal intensity sug-
gesting unstable plaque); and (c) remodeling patterns (positive remodeling sug-
gesting outward expansion of the vessel wall) [63].
On the contrary, superiorly located MCA plaques (near to the orifices of pen-
etrating arteries) are associated with BOD-type ICAD [64].
Bodle asserted that, in other vascular beds, the determination of atherosclerotic 
plaque constituents has helped in risk-stratify patients and select treatments. Using 
clinical, imaging, and pathological correlations, studies of coronary and carotid 
artery disease have detected characteristics that indicate plaque vulnerability: lipid 
core size, intraplaque hemorrhage, and fibrous cap thickness. These vulnerable 
plaque characteristics are also present in ICAD [50, 65] but are less well studied 
(Table 3). Bodle also noted that intraplaque hemorrhage (IPH) from rupture of 
plaque microvessels causing the accumulation of erythrocyte membranes, deposi-
tion of cholesterol, macrophage infiltration and enlargement of the necrotic core 
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results in atheroma growth, and plaque destabilization. A large amount of lipid 
within the necrotic core of a plaque is another sign of plaque vulnerability HR-MRI 
measurement of lipid-necrotic core area in extracranial ICA plaques correlates well 
with pathology [50].
HR-MRI can identify fibrous cap characteristics (thin, thick, or ruptured) in 
extracranial ICAs. The fibrous cap is a layer of connective tissue covering the lipid-
necrotic core. Thick fibrous caps are less prone to rupture [50].
HR-MRI is noninvasive, but less available, still with limited clinical value, 
requiring extensive postprocessing. Bodle asserted that imaging characteristics in 
ICAD have not yet been correlated with pathological specimens because, while the 
HR-MRI of the extracranial ICAs can be correlated with endarterectomy speci-
mens, intracranial vessels are not accessible to pathology sampling in live patients. 
Therefore, the signal characteristics of intracranial plaque components can only be 
extrapolated from extracranial ICAs HR-MRI [50].
Another disadvantage is the small size (2.0–5.0 mm) and the depth of the 
intracranial vessels, which require relatively long acquisition times, making 
HR-MRI imaging difficult because of patient motion artifact and limitations in 
resolution.
According to Bodle, HR-MRI can help to identify stroke mechanisms, determine 
the degree and etiology of stenoses, identify nonstenotic plaques, and identify 
potentially high-risk plaque components. These plaque characteristics are not 
visualized with conventional luminal imaging and may be important predictors of 
stroke [50].
6.  Multidetector computed tomography and multidetector computed 
tomography angiography for the diagnosis of intracranial 
atherosclerotic disease (ICAS)
6.1 Nonenhanced multidetector computed tomography (MDCT)
The study of the prevalence, and of the risk factors for intracranial internal 
carotid artery calcification (ICAC), as a marker of intracranial atherosclero-
sis was determined by Bos and coworkers. They assessed a white population 
(2495 persons) from the population-based Rotterdam Study with a no enhanced 
multidetector (16-slice or 64-slice) computed tomography (MDCT) of the 
intracranial ICAs. A calcified plaque had >130 Hounsfield units. They con-
cluded that ICAC was highly prevalent and occurred in over 80% of older, white 
persons [66].
Plaque 
characteristic
TOF-MRA T1-weighted PD-weighted T2-weighted
Fibrous cap Isointense/
hypointense
Isointense Isointense/
hyperintense
Hyperintense
Lipid-rich 
necrotic core
Isointense Isointense/
hyperintense
Hyperintense Hypointense
Hemorrhage Hyperintense Hyperintense to 
hypointense (with 
age of hemorrhage)
Hypointense to 
hyperintense
Hypointense to 
hyperintense
Calcification Hypointense Hypointense Hypointense Hypointense
Table 3. 
Plaque characteristics on multiple contrast weightings based on carotid imaging literature [50, 65]
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6.2 Multidetector computed tomography angiography (MCTA)
A comprehensive high-resolution intracranial vessel assessment is possible by 
the introducing of multislice CT (MSCT: multiple row scanning: 4, 16, 64, up to 
320 rows, associated with an increased rotational speed: 0.5 s/rotation). MSCT 
represents the first-line imaging modality in stroke patients [67]. CTA calculates 
the degree of stenosis using the published method for the Warfarin-Aspirin 
Symptomatic Intracranial Disease Study (WASID) (vide supra) [2].
According to Arenillas, CTA detects the degree of stenosis for each of 15 large 
intracranial arterial segments assessed: bilateral supraclinoid ICAs, A1-ACA, 
M1-ACM, M2-ACM, P1-PCA, proximal, mid, and distal BA, and intracranial 
VA. CTA identifies and characterizes the ICAS of different histopathological nature 
(including partially recanalized emboli), being unable to directly assess plaque 
instability. It allows the examination of ICAS progression and in-stent restenosis 
[3, 68]. The stenotic lesions are considered to be atherosclerotic in nature, if no 
cases with subarachnoid hemorrhage or intracerebral hemorrhage are detected by 
CT head (in consequence, vasospasm is unlikely the cause of these ICAS). Arterial 
segments are excluded from the analyses of stenosis, if they are identified to be 
congenitally hypoplastic or seen only through collaterals or cross-filling [69].
The prevalence, distribution, calcification, and the risk factors predisposing 
ICAS in a white stroke population were investigated by Homburg and coworkers. All 
patients underwent MDCT of the brain and MDCTA (with a 16-slice MDCT scanner 
or a 64-slice MDCT scanner with a standardized protocol) of the extracranial and 
intracranial arteries in a single session [70]. They concluded that the majority of 
ICAS was observed in the posterior circulation. ICAS in the proximal intracranial 
arteries was mainly classified, but in distal arteries, it was frequently nonclassified, 
indicating a different pathophysiology of atherosclerotic disease in the two segments. 
The absence of calcification on CT of the brain does not exclude the presence of 
ICAS in the distal arteries. Association of nonclassified ICAS and ESR may indicate a 
prominent role for inflammatory factors in intracranial arteries disease (ICAD) [71].
6.3 CTA versus DSA
CTA was compared with DSA for the detection and measurement of stenosis/
occlusions in large intracranial arteries by Nguyen and coworkers [69]. They 
reported high sensitivity and a high PPV for CTA for the detection of occlusion 
and stenosis of greater than 50%. CTA has relatively fewer risks, costs less, is more 
readily available, and appears to have the same accuracy as DSA, to identify the 
exact site of arterial occlusion in acute ischemic stroke. Maximum intensity projec-
tions and volume rendering can help to quickly identify the occlusion. On the other 
hand, CTA does not appear to be as reliable as DSA for determining the presence of 
stenosis in small arteries distal to the first 1 cm of the artery [72].
6.4 CTA versus MRA
CTA has several advantages compared with MRA: better anatomic visualization 
of the circle of Willis and of the state of the arteries [73] and quite accurate in the 
evaluation of stenosis, since the latter tends to overestimate high-grade stenosis 
attributable to turbulent flow; CTA is more accurate for identifying occlusion (sen-
sitivity, 100%; specificity, 99.4–100%) than for measuring the degree of stenosis 
[68]. CTA is minimally invasive, performed quickly, modest cost, scanner availabil-
ity 24/7, operator-independent, less susceptible to motion artifacts than MRA, and 
less dependent on hemodynamic effects compared with MRA [68, 69, 74, 75].
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Its disadvantages, besides radiation risk exposure, are patient movement, 
contrast risk reactions (allergy to iodine contrast agents), different contra-
indications (nephron-toxicity-serum creatinine levels >1.2 mg/dL, etc.), and 
difficult evaluation of arteries within bone canals (particularly of the carotid 
siphon) due to bone artifacts. However, intracranial, with the proper examina-
tion and postprocessing techniques, is possible to use CTA to assess the petrous 
and cavernous portions of the ICA. Multiplanar reformation (MPR) can display 
2D images in various planes without any loss of information. Maximum inten-
sity projection (MIP) enhances high attenuation contrast tissues, including 
bone, wall calcification, or blood vessels. Since calcifications can interfere with 
the evaluation of the degree of stenosis, bone elimination is done during post-
processing [68, 69].
6.5 CTA versus 3D-TOF-MRA and DSA
Bash et al. [76] retrospectively examined 28 subjects with ischemic stroke or 
TIA comparing CTA and MRA using DSA as the gold standard, among intracranial 
arteries with stenosis >30% (anterior circulation vessels 42 versus 58% posterior 
circulation arteries). They concluded that CTA demonstrated a higher sensitivity, 
specificity, and PPV than those of MRA for the evaluation of stenotic and occluded 
intracranial vessel segments. CTA has a high interoperator reliability for the quan-
titation of stenotic lesions when expert readers are used. Helical CTA is superior to 
DSA in the demonstration of arterial patency in posterior circulation arteries when 
very low- or balanced flow states are present due to a severe stenosis [76]. In the era 
of the mechanical thrombectomy with stent-retriever, when faster puncture time 
to endovascular therapy became very important, CTA became essential due to its 
shorter scan time and the evaluations of collaterals on multiphase imaging, which 
can contribute to faster recanalization and better evolution [68].
6.6 CTA versus DSA versus TCCS
Roubec and coworkers compared ICAS in 67 patients with stroke using three 
different methods: TCCS, CTA, and DSA in a common clinical practice. They found 
substantial agreement between CTA and DSA, and moderate agreement between 
TCCS and DSA as well as CTA and TCCS, for the evaluation of ICAS [77].
6.7 Intracranial nonocclusive thrombosis (iNOT)
The frequency and clinical course of patients with acute ischemic stroke or TIA 
who had intracranial nonocclusive thrombus (iNOT) on CTA of the circle of Willis 
were assessed by Puez and coworkers [78]. Before CTA, a noncontrast CT (NCCT) 
was accomplished in all cases. iNOT has been described first on DSA or MRA [79, 
80]. Criteria to diagnose iNOT rather than occlusive thrombus or atherosclerotic 
stenosis were: (1) residual lumen present and eccentric; (2) nontapering thrombus; 
(3) smooth and well-defined thrombus margins; and (4) absence of vessel wall 
calcification [78]. Puez concluded that iNOT was relatively uncommon. Probably, 
iNOT may be more frequently diagnosed when performing early CTA in such 
patients. The majority of patients had a good clinical outcome. Clinical deteriora-
tion was associated with unchanged or enlarged iNOT in repeated vascular studies, 
whereas diminished or resolved iNOT was associated with a benign clinical course. 
Particularly, in patients with minor symptoms, iNOT may indicate increased risk 
for clinical deterioration. Puez’s study supported the importance of urgent vascular 
imaging in these patients [78].
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Clot length can be examined by thin-sliced noncontrast CT and CTA. A better 
visualization of collateral circulation (which is an important prognostic factor for 
favorable outcome) can be realized with multiphase CTA [81, 82].
7. Conclusions
This chapter focuses on key findings and recent approaches in diagnosis of 
intracranial arterial atherosclerotic stenosis (ICAS), with an emphasis on novel 
procedures to define the underlying mechanisms of stroke in intracranial athero-
sclerotic disease (ICAD). The importance of ICAS as a principal cause of ischemic 
stroke in Caucasians is undervalued as compared to that of extracranial athero-
sclerotic stenosis (ECAS) and nonvalvular atrial fibrillation (NVAF). On the other 
hand, intracranial arterial calcifications, stenosis, and occlusions represent the 
most frequent disturbance observed in intracranial arteries [83].
Intracranial arterial stenosis is caused by an atherosclerotic plaque in more than 
90% of cases (ICAS). Intracranial atherosclerotic stroke differs from extracranial 
atherosclerotic stroke in many aspects, including risk factors and stroke patterns. 
Unlike in patients with ECAS or NVAF, stroke correlated to ICAD occurs in associa-
tion with various stroke mechanisms such as in situ thrombotic occlusion, artery-
to-artery embolism, branch occlusion, and hemodynamic insufficiency [83].
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